Health Economics and Payer Evidence Lead / Director, Oncology (12 month secondment or fixed-term contract)
Location: Cambridgeshire, Gaithersburg, Maryland
Job Type: Full time
Health Economics and Payer Evidence Lead/Director, Oncology
Cambridge, UK or Gaithersburg, US
Depending on experience we can consider F or G level
This role is office based 3 days per week
AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines for some of the world’s most serious diseases.
ONCOLOGY BUSINESS UNIT
We’re all here to make an impact – to achieve our bold ambition of eliminating cancer as a cause of death.
In the Oncology Business Unit we relentlessly follow the science, challenging the status quo to deliver more effective treatments to patients in need. Our commitment means we purposefully push back the limits of knowledge to change the practice of medicine. To ensure no patient is left behind, no matter what stage of disease.
WHY JOIN MARKET ACCESS AT ASTRAZENECA?
Join a highly valued, strategic team that is fundamental in realising the potential of our life-changing medicines. It’s through our work that AstraZeneca is able to ensure the right access is provided to our transformative medicines.
Working with new drugs, new digital approaches and ever-changing environments, it’s crucial that we remain flexible and on top of the detail. Running, thinking and acting fast to make smart decisions and get the right medicines to patients at the right time.
We lead the way for the industry with our pioneering valued-based agreements and Innovative Value Strategy solutions. It’s our determination and unwavering belief in the power of our medicines, and the science sitting behind them, that drives us to ensure their value is realised.
Inspired by our people, patients and pipeline, we work cross-functionally to leverage our shared skills, knowledge and entrepreneurial spirit to change the way medicines are assessed and perceived, and turn ambitions into reality.
We’re pioneering Market Access innovations: this is the place to unlock opportunities and feed our love for the challenge. United by an unrivalled passion for patients and science and always performing at the top of our game.
HEALTH ECONOMICS AND PAYER EVIDENCE DIRECTOR – WHAT YOU’LL DO:
The successful candidate will work closely with the Breast Cancer Pricing and Market Access Directors, the HEPE team across brands and indications, the Simulation and Analytics team, the IVS team, our marketing companies (local affiliates), and cross functionally – Globally and Regionally, with an expectation that they will make impact into strategic discussions across R&D, medical and commercial.
Collaborate with cross functional R&D, commercial, medical, regional and country teams to develop, launch and commercialise AstraZeneca Oncology medicines.
High quality health economics and payer evidence input into pharmaceutical development projects, payer evidence strategy and plans, and market access & pricing strategies
Matrix management of a cross functional team to support the development of payer strategy and evidence including payer statistical analyses, patient reported outcomes, health economics and real-world evidence.
Independently execute and deliver brand-level health economics and payer evidence related activities, including economic models, indirect comparison/network meta-analysis, Global Reimbursement dossier (GRD), payer-focused clinical trial analysis, etc, to ensure optimal access of our life changing medicines to patients
Ensure target product profiles and target claims can meet payer needs and necessary supporting evidence is developed.
Apply your knowledge to support decision-making processes, value demonstration and commercialization of products including through Health Technology Assessment (HTA).
Advocate and champion the need for scientifically sound trial and non-trial data (including RWE, economic modelling, meta-analyses, observational studies, and PRO approaches).
Contribute and lead payer evidence discussions in relevant cross-functional team meetings – eg GPT (Global Product Team), IBT (Integrated Brand Team), RSST (Regulatory Submission Strategy Team), RWE Strategy team.
Lead and deliver the health economics related activities for an innovative therapy in Breast Cancer, prepare for a successful payer launch across our key markets and collaborate with local affiliates in preparing evidence that satisfies local payer requirements.
Contribute to peer reviewed scientific publications, as well as effective communication of complex ideas for use with both payers and other stakeholders.
Participate in external health economics and payer evidence departmental activities via technical presentations, committee membership, publication reviews, and other similar activities.
Interact with HTA authorities and advisors/key external experts in preparing materials for scientific advice or reimbursement submissions.
Raise the profile of access internally and externally
Graduate degree in health economics, biomedical science, business, or a related quantitative discipline.
Oncology therapy area experience, local or global launch experience
Over 7-year’s working experience in health economics, market access, and pricing, ideally having worked at a senior level within a health economic consultancy or several years in a pharmaceutical company.
Ability to communicate technical matters in a clear, compelling and impactful way with others via a range of media (e.g. face to face, teleconferences, video conferences, formal presentations, strong scientific writing for reports, analysis plans and emails).
Ability to work both collaboratively and independently, understand and apply different technical approaches, and have wide understanding of different HTA systems.
Global payer launch experience and global payer evidence development experience.
Develops and uses internal and external networks, including leading academic and information bodies, to shape future trends in analytical techniques and to ensure that that the most up-to-date analytical techniques are being applied to maximise payer leverage.
Self-starter, learning agility, can-do attitude, and team player.
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorisation and employment eligibility verification requirements. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or protected veteran status.
AstraZeneca requires all US employees to be fully vaccinated for COVID-19 but will consider requests for reasonable accommodations as required by applicable law.